John Sfakianos

9PUBLICATIONS
90CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyRadiation therapyCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 19, 2026
Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial.

|Mar 17, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky

|Feb 26, 2026
A Tumor-Promoting Inflammatory SPP1+ Macrophage-IL6-CRP Axis Drives Immune Dysfunction in Bladder Cancer.

Michelle A Tran, Byuri Angela Cho, Sudeh Izadmehr

|Jan 23, 2025
Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.

Reuben Ben-David, Francesco Pellegrino, Reza Mehrazin

|Oct 16, 2024
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes.

Reuben Ben-David, Sarah Lidagoster, Jack Geduldig

|Jun 07, 2024
Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment.

Michelle A Tran, Dina Youssef, Sanjana Shroff

Pageof 2

Frequent Collaborators

7 joint publications

Reza Mehrazin

5 joint publications

Peter Wiklund

4 joint publications

Reuben Ben-David

4 joint publications

Matthew D Galsky